CANSF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
8.74M
CRLBF
Price
$0.89
Change
+$0.01 (+1.14%)
Updated
Jan 17 closing price
Capitalization
501.04M
53 days until earnings call
Ad is loading...

CANSF vs CRLBF

Header iconCANSF vs CRLBF Comparison
Open Charts CANSF vs CRLBFBanner chart's image
Willow Biosciences
Price$0.05
Change-$0.00 (-0.00%)
Volume$6.05K
Capitalization8.74M
Cresco Labs
Price$0.89
Change+$0.01 (+1.14%)
Volume$615.53K
Capitalization501.04M
CANSF vs CRLBF Comparison Chart
Loading...
CANSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANSF vs. CRLBF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANSF is a Hold and CRLBF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CANSF: $0.05 vs. CRLBF: $0.89)
Brand notoriety: CANSF and CRLBF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CANSF: 10% vs. CRLBF: 77%
Market capitalization -- CANSF: $8.74M vs. CRLBF: $501.04M
CANSF [@Pharmaceuticals: Other] is valued at $8.74M. CRLBF’s [@Pharmaceuticals: Other] market capitalization is $501.04M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANSF’s FA Score shows that 0 FA rating(s) are green whileCRLBF’s FA Score has 0 green FA rating(s).

  • CANSF’s FA Score: 0 green, 5 red.
  • CRLBF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CANSF and CRLBF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANSF’s TA Score shows that 4 TA indicator(s) are bullish while CRLBF’s TA Score has 4 bullish TA indicator(s).

  • CANSF’s TA Score: 4 bullish, 3 bearish.
  • CRLBF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both CANSF and CRLBF are a good buy in the short-term.

Price Growth

CANSF (@Pharmaceuticals: Other) experienced а +2.20% price change this week, while CRLBF (@Pharmaceuticals: Other) price change was -5.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.30%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was -9.85%.

Reported Earning Dates

CRLBF is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRLBF($501M) has a higher market cap than CANSF($8.74M). CANSF YTD gains are higher at: 26.173 vs. CRLBF (-2.597). CANSF has higher annual earnings (EBITDA): -10.02M vs. CRLBF (-16.73M). CRLBF has more cash in the bank: 88.8M vs. CANSF (3.68M). CANSF has less debt than CRLBF: CANSF (1.66M) vs CRLBF (678M). CRLBF has higher revenues than CANSF: CRLBF (822M) vs CANSF (1.59M).
CANSFCRLBFCANSF / CRLBF
Capitalization8.74M501M2%
EBITDA-10.02M-16.73M60%
Gain YTD26.173-2.597-1,008%
P/E RatioN/AN/A-
Revenue1.59M822M0%
Total Cash3.68M88.8M4%
Total Debt1.66M678M0%
FUNDAMENTALS RATINGS
CANSF vs CRLBF: Fundamental Ratings
CANSF
CRLBF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
6091
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRLBF's Valuation (62) in the null industry is in the same range as CANSF (94). This means that CRLBF’s stock grew similarly to CANSF’s over the last 12 months.

CRLBF's Profit vs Risk Rating (100) in the null industry is in the same range as CANSF (100). This means that CRLBF’s stock grew similarly to CANSF’s over the last 12 months.

CRLBF's SMR Rating (94) in the null industry is in the same range as CANSF (100). This means that CRLBF’s stock grew similarly to CANSF’s over the last 12 months.

CANSF's Price Growth Rating (60) in the null industry is in the same range as CRLBF (91). This means that CANSF’s stock grew similarly to CRLBF’s over the last 12 months.

CANSF's P/E Growth Rating (93) in the null industry is in the same range as CRLBF (100). This means that CANSF’s stock grew similarly to CRLBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CANSFCRLBF
RSI
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 12 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
89%
Momentum
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 12 days ago
80%
MACD
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 12 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 12 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
88%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 24 days ago
88%
Bearish Trend 25 days ago
87%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
87%
View a ticker or compare two or three
Ad is loading...
CANSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNCSX33.510.26
+0.78%
Franklin Natural Resources R6
TCMGX21.160.15
+0.71%
Nuveen Mid Cap Growth A
JVTAX80.200.39
+0.49%
Janus Henderson Venture A
MPZRX9.570.04
+0.42%
MassMutual Strat Emerg Mkts R3
VWINX25.070.05
+0.20%
Vanguard Wellesley® Income Inv

CANSF and

Correlation & Price change

A.I.dvisor tells us that CANSF and LNTH have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANSF and LNTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANSF
1D Price
Change %
CANSF100%
+1.49%
LNTH - CANSF
21%
Poorly correlated
-0.12%
VTRS - CANSF
21%
Poorly correlated
-0.35%
CANQF - CANSF
6%
Poorly correlated
-26.20%
CNPOF - CANSF
1%
Poorly correlated
N/A
CRLBF - CANSF
1%
Poorly correlated
+0.63%
More

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TSNDF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+0.63%
TSNDF - CRLBF
76%
Closely correlated
+8.08%
CURLF - CRLBF
76%
Closely correlated
+10.22%
TCNNF - CRLBF
75%
Closely correlated
+1.43%
JUSHF - CRLBF
74%
Closely correlated
+4.33%
VRNOF - CRLBF
73%
Closely correlated
+8.27%
More